Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease
Julia Tuominen(Norwegian Womens Public Health Association), Jannicke Igland(Western Norway University of Applied Sciences), Trond Riise, Marianna Cortese(Harvard University), Clemens R. Scherzer(Brigham and Women's Hospital), Julia Romanowska(Norwegian Womens Public Health Association), Kjetil Bjørnevik(Harvard University), Thomas B Grydeland(Haukeland University Hospital), Magne H Solheim(University of Bergen)
Cited by 6
Related Papers
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease
|Proceedings of the National Academy of Sciences|2010|661
Meta‐analysis of Parkinson's Disease: Identification of a novel locus, <i>RIT2</i>
|Annals of Neurology|2011|299
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
|JAMA Neurology|2019|270
Smoking is a risk factor for multiple sclerosis
|Neurology|2003|250